ABSTRACT The primary structure of the murine J chain was investigated by sequence analysis ofthe J chain cDNA inserts from two independently cloned chimeric plasmids. The sequence data showed that (i) the two cDNA inserts accounted for all but approximately 100 5' nucleotides of the J chain mRNA and (ii) the J chain mRNA encodes a prepeptide of at least 23 amino acids, a mature protein of 137 residues, and an untranslated 3' region of 707 nucleotides exclusive of the 3' poly(A) tract. The amino acid sequence deduced for the mature mouse J chain was found to be 74% identical with that previously determined for the human J chain. By analyzing the conserved features ofthe sequence, a twodomain structure was generated for the J chain which correlates well with its functions in the polymerization of IgM and IgA. Moreover, by comparing the homologies of the J and heavy chains in mouse and man, evidence was obtained that the structures involved in polymerization are the most conserved elements of immunoglobulin molecules.
Considerable progress has been made in defining the functions of the immunoglobulin J chain. It has been found to play a critical role at two different stages of the immune response, first in the synthesis of the primary antibody product, pentamer IgM, and later in the synthesis of the major secretory antibody, polymeric IgA (1, 2) . Studies of Ig polymer biosynthesis have shown that the J chain joins two monomer subunits by forming a disulfide bridge between penultimate cysteine residues in the monomer heavy chains (3, 4) . In the case of IgM, the J chaincontaining dimer serves as a nucleating unit to promote disulfide bonding of other IgM monomers and to complete the pentamer structure. In the case of IgA, the J chain-containing dimer is usually secreted directly from the cell, but it can induce the formation of larger polymers (5) . The J chain has also been found to play a critical role in the transport of polymeric IgA to the exocrine secretions (6) . Only J chain-containing polymers appear to be capable of interacting with secretory component (7) , the protein that ferries the immunoglobulin across the epithelial cell wall.
In contrast, relatively little progress has been made in correlating the functions of J chain with its structure. Such studies have been hampered by the lack ofmutant forms of J chain that display altered function as well as by the difficulty in isolating enough J chain for detailed biochemical characterization. Because the J chain comprises a minor fraction of the polymer protein and is highly susceptible to enzymatic degradation (8) , only the human J protein has been obtained in sufficient quantities to permit sequence determination (9) . Finally, it has not been possible to study the native conformation ofJ chain as the sreducing conditions required to free the J chain from Ig polymers also reduce the intra-J chain disulfide bonds (10) .
The recent development of recombinant DNA technology has provided the means to overcome some of these difficulties.
In this paper we report the primary structure of the murine J chain that was derived by sequence analysis of cloned cDNA. By comparing the data obtained with that available for the human polypeptide, the conserved features of the J chain could be identified and used to deduce structure-function relationships.
MATERIALS AND METHODS cDNA Synthesis and Cloning. Tritium-labeled cDNA was synthesized by using as a template the poly(A)-containing RNA from the murine hybrid cell line M x W 231. lb (11, 12) . After double-stranding, the cDNA was treated with nuclease Si (Miles) to generate blunt ends (13) (14) . The EcoRI-adapted cDNA was size-fractionated by sedimentation through a 15-30% sucrose gradient at 4°C for 18 hr at 34,000 rpm in a Beckman SW 41 rotor. Three fractions containing the largest EcoRI-adapted cDNAs were treated with EcoRI and ligated into the single EcoRI site ofCharon 16A (15) . Phage genomes were packaged in vitro and the resultant phage library was plated on Eschericha coli K802. Recombinant phages were screened by hybridization (16) with a cloned cDNA, pJc3 (17) , which was 32P-labeled by nick-translation (18) . Phages containing hybridizing cDNA were plaque-purified and the cDNA inserts were subcloned into a derivative, pBEU50, of the ts runaway-replication plasmid (19) . Plasmid amplification was achieved by shifting an exponentially growing culture of E. coli HB101 harboring the recombinant plasmid (OD600 = 0.5-1.0) from 30°C to 37°C. After 2 hr of vigorous shaking the plasmid DNA was isolated from the cells by the cleared lysate procedure (20) .
DNA Sequence Analysis. The nucleotide sequence was determined by the method of Maxam and Gilbert (21) with the modified conditions for piperidine removal and electrophoresis described by Smith and Calvo (22) .
Primer Extended cDNA Synthesis. cDNA was synthesized to the 5' end of J chain mRNA by using as a primer an end-labeled restriction fragment from the 5' end ofJc21. The primer was prepared by isolating the 150-base-pair (bp) EcoRI-BamHI restriction fragment of Jc21, labeling the 5' ends with polynucleotide kinase (New England BioLabs) and [ were found to extend 98 ± 10 bases (±SEM) beyond the 5' terminus of the Jc21 cDNA sequence. From this information it was calculated that the mature J chain message consists of 1,290 ± 10 nucleotides (±SEM) plus a poly(A) tract of 57 or more residues. These data are consistent with the size of the message as determined by gel electrophoresis (17) , provided a correction is made for the drag effect of the poly(A) tail on the mobility of the RNA (R. Perry, personal communication).
The amino acid sequence deduced for the murine J chain is presented along with the nucleotide sequence in Fig. 2 . The murine J chain mRNA was found to encode at least 160 amino acids, more than that expected for the mature J protein. By comparing the mouse data with the amino acid sequence determined for the human J protein (9) , the extra amino acids appeared to comprise part of an amino-terminal signal peptide. The precise boundary between the signal peptide and the mature J peptide could not be definitely assigned because the amino-terminal residue ofthe mouse J chain has yet to be identified. However, by analogy to the human sequence (Fig. 3) , it seems likely that the signal peptidase cleaves between a glycyl and an aspartyl residue to yield a signal peptide of at least 23 amino acids and a mature J chain of 137 amino acids. Cleavage at this point would mean that Jc21 cDNA contains most of the prepeptide information but lacks a few 5' codons including the initial AUG. Cleavage at this point would also imply that the mouse J chain has an unblocked amino-terminal residue in contrast to the cyclized glutamic acid found in the human J chain (9) .
As predicted from its size (17), the mouse J chain mRNA was found to have a large 3' untranslated region, extending 707 nucleotides. This length falls within the upper range of the values reported for the 3' untranslated regions of other eukaryotic mRNAs (24) . A single polyadenylylation signal was found to be present =20 nucleotides 5' from the poly(A) tract. Rather than the consensus hexanucleotide, A-A-U-A-A-A, the signal here appears to be the variant heptanucleotide, A-A-U-U-A-A-A, which has also been identified in rat amylase mRNA (24) and anglerfish pancreatic somatostatin mRNA (25) .
Homology Between Mouse and Human J Chains. The amino acid sequences of the mature mouse and human J chains are compared in Fig. 3 . Because the mouse J chain was found to contain eight more amino acid residues than the human protein, three gaps were inserted in the human J chain sequence to maximize the homology. With value of 74% homology indicates that the J chain has been highly conserved over evolutionary time. In particular, features important to the three-dimensional structure have been maintained. Thus, both the mouse and the human J chains contain eight cysteine residues, seven of which occupy identical positions in the sequence, and both polypeptides display stretches ofdistinctly hydrophobic residues that alternate in the sequence with stretches of more hydrophilic character (see Fig. 4 ).
These findings are consistent with other evidence for J chain conservation. In vitro polymerization studies have shown that the human J chain can substitute for the mouse J chain in promoting the assembly of mouse pentamer IgM (unpublished observations). Immunological analyses have shown that the human J chain shares determinants with the J protein from descendants ofprimitive vertebrates, such as the dogfish and leopard sharks (2) . DISCUSSION By combining the sequence data presented in this paper with the information available on J chain cystine bridges, it was possible to deduce a two-domain structure for the J chain that is shown schematically in Fig. 4 . Analysis of the sequence data revealed that the two halves of the J polypeptide have very different characteristics. The sequence in the amino-terminal half exhibits a mirror-image symmetry that is bounded by the two sets of cysteine residues and includes the intervening stretches of hydrophobic and hydrophilic residues. In contrast, the sequence in the carboxyl-terminal half shows no apparent symmetry except for the repeating Cys-Tyr sequence. Analyses of the disulfide content of the polymeric immunoglobulins have shown that all the J chain cysteines are linked in intra-or interchain bonds (3). Moreover, cysteine-15 has been implicated in one of the interchain bonds; a tripeptide with a sequence identical to that at positions 15-17 of the human J chain was found to be linked to the penultimate cysteine residue in human polymeric IgA (26) . These considerations ofprimary and tertiary structure suggested to us that the amino-terminal half of the J chain is folded so that an internal disulfide bond is formed between two of the distant cysteine residues. The result would be a symmetrically arranged domain with one cysteine of each set (including cysteine-15) available for intermonomer linkage. On the other hand, the features of the carboxyl-terminal half of the J chain suggested that the folding is less regular and allows the cysteines to form internal bonds spanning relatively short stretches of sequence. This would create a second domain of distinctly different structure.
A two-domain model is consistent with predictions ofJ chain secondary structure. Analyses of the sequence by the method of Chou and Fasman (27) indicate that the proposed domains have very different conformational properties. The sequence within the amino-terminal disulfide loop was calculated to have a high potential for forming three pleat segments (Po for residues 15-23, 37-44, and 61-69 = 1.23, 1.28, and 1.17, respectively) connected by stretches of random coil. Such a conformation would facilitate the interaction of this domain with the /3-pleated structure assigned to the carboxyl-terminal domain of IgM or IgA (28) . In contrast, the second J chain domain is predicted to have three helical segments (P. for residues 4-10, 74-85, and 122-130 = 1.21, 1.20, and 1.24, respectively). The intervening sequence, residues 87-120, is computed to be random coil interrupted by two short pleat segments.
The proposed two-domain structure is also supported by data on J chain proteolysis. The J polypeptide in human or murine pentamer IgM is highly susceptible to digestion with subtilisin, quantitative cleavage being achieved after brief treatment at very low enzyme to IgM ratios (8) . Analysis of the digested J chain has shown that the initial cleavage occurs in an exposed region midway in the sequence. The amino-terminal halfofthe J chain remains associated with the pentamer and resists degradation, whereas the carboxyl-terminal half is released and then digested into smaller peptides. This cleavage pattern confirms two assumptions ofthe proposed structure-namely, that both J-monomer bonds are located in the amino-terminal half of the molecule and the amino-terminal, but not the carboxylterminal, portion of the J chain is in close contact with the Cu4 domains of the IgM subunits. Analyses of the digested pentamer have indicated that its three-dimensional structure remains intact; no changes could be detected by electrophoretic or ultracentrifuge measurements in various solvents (8, 29) . Moreover, the digested pentamer retains most of its capacity to fix complement and bind secretory component (29) . Thus, it would appear that the polymerizing function of the J chain resides in its amino-terminal half, whereas the function of the carboxylterminal half of the molecule remains to be determined.
It should be emphasized that the model shown in Fig. 4 represents a tentative structure ofJ chain. Although the proposed two-domain arrangement is substantiated by experimental data, many of the intradomain features-e.g., the assignment of intrachain bonds and the interaction of hydrophobic regionsremain purely hypothetical. It may be possible to ascertain the location ofthe J chain disulfide bridges by using chemical cleavage methods (9) , but the resolution of other features of the J chain structure will require analysis of the three-dimensional structure ofthe parent polymers. Until such studies are accomplished, the proposed model can serve as a useful framework for probing the structure-function relationships of the J chain.
In addition to providing insight into the structure ofJ chain, the sequence data reported here made it possible to assess the conservation of both the J chain and the polymerization process. When the sequences of the mouse and human J chains were compared, the two proteins were found to be highly homologous, ranging from 79% identity in the amino-terminal "domain" to 69% in the carboxyl-terminal domain (Table 1) . Similar homologies have been observed for the regions of the IgM and IgA monomers that are involved in the polymerization process. These include the carboxyl-terminal constant domains and the adjoining 19 -residue tails that are unique to secreted tL and a chains and contain the penultimate cysteine residue through which polymerization is effected (1, 2) . Kehry et al. (30) have found that the carboxyl-terminal regions of ,u chains are considerably more conserved than the amino-terminal regions, and similar results have recently been obtained for a chains (31) . The mouse and human data from these studies are presented in Table 1 The question then arises as to why the polymerization process has been maintained over the evolution of the immunoglobulins. Although pentamer IgM was the first functional antibody to appear in the primitive vertebrates, monomeric forms with generally higher antigen affinity and specificity have subsequently evolved. Moreover, the organization ofthe heavy chain gene locus indicates that the synthesis of the secreted forms of uand a chains could be bypassed (34) . One possible explanation for the conservation is that the polymeric antibodies play an essential role in protection against disease, pentamer IgM by acting at the early stages ofinfection and polymeric IgA by protecting the body surfaces from colonization by pathogens. Because of their multivalence, the polymeric antibodies could effectively complex those pathogens displaying repeating sets of determinants on their surface. A second possible explanation is that the polymerization of IgM is an obligatory step in the differentiation of the antibody-producing cell. Some component of the polymerizing system, pentamer IgM itself, or a byproduct generated during its synthesis, may be required to signal the switch in immunoglobulin class synthesis that follows the pentamer IgM response. By pursuing the analysis of the polymerizing system at the molecular level, it should be possible to resolve the question of its function and thus of its high degree of conservation.
